190 related articles for article (PubMed ID: 34042908)
1. Posttreatment Lyme Disease Syndrome-What It Might Be and What It Is Not.
Schmid H; Heininger U
Pediatr Infect Dis J; 2021 May; 40(5S):S31-S34. PubMed ID: 34042908
[TBL] [Abstract][Full Text] [Related]
2. Update of the Swiss guidelines on post-treatment Lyme disease syndrome.
Nemeth J; Bernasconi E; Heininger U; Abbas M; Nadal D; Strahm C; Erb S; Zimmerli S; Furrer H; Delaloye J; Kuntzer T; Altpeter E; Sturzenegger M; Weber R; For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology
Swiss Med Wkly; 2016; 146():w14353. PubMed ID: 27922168
[TBL] [Abstract][Full Text] [Related]
3. A Review of Post-treatment Lyme Disease Syndrome and Chronic Lyme Disease for the Practicing Immunologist.
Wong KH; Shapiro ED; Soffer GK
Clin Rev Allergy Immunol; 2022 Feb; 62(1):264-271. PubMed ID: 34687445
[TBL] [Abstract][Full Text] [Related]
4. Stationary phase persister/biofilm microcolony of Borrelia burgdorferi causes more severe disease in a mouse model of Lyme arthritis: implications for understanding persistence, Post-treatment Lyme Disease Syndrome (PTLDS), and treatment failure.
Feng J; Li T; Yee R; Yuan Y; Bai C; Cai M; Shi W; Embers M; Brayton C; Saeki H; Gabrielson K; Zhang Y
Discov Med; 2019 Mar; 27(148):125-138. PubMed ID: 30946803
[TBL] [Abstract][Full Text] [Related]
5. A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients.
Morrissette M; Pitt N; González A; Strandwitz P; Caboni M; Rebman AW; Knight R; D'Onofrio A; Aucott JN; Soloski MJ; Lewis K
mBio; 2020 Sep; 11(5):. PubMed ID: 32994327
[TBL] [Abstract][Full Text] [Related]
6. [Chronic Lyme disease: hype or hypothesis?].
van der Horst HE
Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332040
[TBL] [Abstract][Full Text] [Related]
7. Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.
Weitzner E; McKenna D; Nowakowski J; Scavarda C; Dornbush R; Bittker S; Cooper D; Nadelman RB; Visintainer P; Schwartz I; Wormser GP
Clin Infect Dis; 2015 Dec; 61(12):1800-6. PubMed ID: 26385994
[TBL] [Abstract][Full Text] [Related]
8. Posttreatment Lyme disease syndrome.
Aucott JN
Infect Dis Clin North Am; 2015 Jun; 29(2):309-23. PubMed ID: 25999226
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Response in Patients With Post-treatment Lyme Disease Symptoms/Syndrome.
Fitzgerald BL; Graham B; Delorey MJ; Pegalajar-Jurado A; Islam MN; Wormser GP; Aucott JN; Rebman AW; Soloski MJ; Belisle JT; Molins CR
Clin Infect Dis; 2021 Oct; 73(7):e2342-e2349. PubMed ID: 32975577
[TBL] [Abstract][Full Text] [Related]
10. Management of patients presenting with generalized musculoskeletal pain and a suspicion of Lyme disease.
Ranque-Garnier S; Eldin C; Sault C; Raoult D; Donnet A
Med Mal Infect; 2019 Mar; 49(2):157-166. PubMed ID: 30765287
[TBL] [Abstract][Full Text] [Related]
11. Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020).
Geebelen L; Lernout T; Devleesschauwer B; Kabamba-Mukadi B; Saegeman V; Belkhir L; De Munter P; Dubois B; Westhovens R; ; Van Oyen H; Speybroeck N; Tersago K
BMC Infect Dis; 2022 Sep; 22(1):756. PubMed ID: 36171561
[TBL] [Abstract][Full Text] [Related]
12. Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data.
Chung MK; Caboni M; Strandwitz P; D'Onofrio A; Lewis K; Patel CJ
EBioMedicine; 2023 Apr; 90():104524. PubMed ID: 36958992
[TBL] [Abstract][Full Text] [Related]
13. Lyme neuroborreliosis.
Koedel U; Pfister HW
Curr Opin Infect Dis; 2017 Feb; 30(1):101-107. PubMed ID: 27820708
[TBL] [Abstract][Full Text] [Related]
14. Sleep quality in well-defined Lyme disease: a clinical cohort study in Maryland.
Weinstein ER; Rebman AW; Aucott JN; Johnson-Greene D; Bechtold KT
Sleep; 2018 May; 41(5):. PubMed ID: 29452400
[TBL] [Abstract][Full Text] [Related]
15. Persistent Symptoms After Treatment of Lyme Disease.
Marques A
Infect Dis Clin North Am; 2022 Sep; 36(3):621-638. PubMed ID: 36116839
[TBL] [Abstract][Full Text] [Related]
16. Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes.
Cabello FC; Embers ME; Newman SA; Godfrey HP
mBio; 2022 Jun; 13(3):e0344021. PubMed ID: 35467428
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of patients with post treatment Lyme disease syndrome treated with modified VFEM energy.
Derderian GP; Otenbaker N
J Cosmet Dermatol; 2024 Jun; 23(6):2044-2048. PubMed ID: 38613155
[TBL] [Abstract][Full Text] [Related]
18. Cimetidine as a novel adjunctive treatment for early stage Lyme disease.
Shemenski J
Med Hypotheses; 2019 Jul; 128():94-100. PubMed ID: 27107653
[TBL] [Abstract][Full Text] [Related]
19. [Lyme borreliosis--an overview].
Egger M
Ther Umsch; 2005 Nov; 62(11):731-6. PubMed ID: 16350535
[TBL] [Abstract][Full Text] [Related]
20. Probable late lyme disease: a variant manifestation of untreated Borrelia burgdorferi infection.
Aucott JN; Seifter A; Rebman AW
BMC Infect Dis; 2012 Aug; 12():173. PubMed ID: 22853630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
